The following ICD-10-CA codes were used to select and exclude ID cases: F70 = Mild mental retardation. F71 = Moderate mental retardation. F72 = Severe mental retardation.
ICD-10 code Z51. 81 for Encounter for therapeutic drug level monitoring is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
R46. 89 - Other Symptoms and Signs Involving Appearance and Behavior [Internet]. In: ICD-10-CM.
ICD-10 code R68. 89 for Other general symptoms and signs is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
Code Z13. 89, encounter for screening for other disorder, is the ICD-10 code for depression screening.
ICD-9 Code Transition: 780.79 Code R53. 83 is the diagnosis code used for Other Fatigue. It is a condition marked by drowsiness and an unusual lack of energy and mental alertness. It can be caused by many things, including illness, injury, or drugs.
F79 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM F79 became effective on October 1, 2021.
Code F41. 9 is the diagnosis code used for Anxiety Disorder, Unspecified. It is a category of psychiatric disorders which are characterized by anxious feelings or fear often accompanied by physical symptoms associated with anxiety.
ICD-10 code F98. 9 for Unspecified behavioral and emotional disorders with onset usually occurring in childhood and adolescence is a medical classification as listed by WHO under the range - Mental, Behavioral and Neurodevelopmental disorders .
R68. 89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM R68. 89 became effective on October 1, 2021.
ICD-10 code Z00. 01 for Encounter for general adult medical examination with abnormal findings is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
NCD 190.15 4. In some patients presenting with certain signs, symptoms or diseases, a single CBC may be appropriate.
A nutritional condition produced by a deficiency of vitamin d in the diet, insufficient production of vitamin d in the skin, inadequate absorption of vitamin d from the diet, or abnormal conversion of vitamin d to its bioactive metabolites.
Therapeutic drug monitoring (TDM) is testing that measures the amount of certain medicines in your blood. It is done to make sure the amount of medicine you are taking is both safe and effective. Most medicines can be dosed correctly without special testing.
F90. 1, Attention-deficit hyperactivity disorder, predominantly hyperactive type. F90. 2, Attention-deficit hyperactivity disorder, combined type.
ICD-10-CM Codes that Support Medical Necessity For monitoring of patient compliance in a drug treatment program, use diagnosis code Z03. 89 as the primary diagnosis and the specific drug dependence diagnosis as the secondary diagnosis.